Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8659792 | Heart, Lung and Circulation | 2018 | 11 Pages |
Abstract
This systematic review and meta-analysis suggests that, based on current literature and data, there has been no conclusive evidence that any antiarrhythmic agents improve rates of ROSC, survival to admission, survival to discharge or neurological outcomes. Given the side effects of some of these agents, we recommend further research into their utility in current cardiopulmonary resuscitation guidelines.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Amelia MBBS, Brian MBBS, Thomas M. MBBS, BMedSci, Leigh D. MBBS, BSc, Grad Dip (ClinUS),